Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Hemodial Int ; 25(1): E1-E5, 2021 01.
Article in English | MEDLINE | ID: mdl-33015942

ABSTRACT

Coronavirus disease 2019 (COVID-19) is a highly infectious disease caused by the severe acute respiratory syndrome coronavirus 2 virus (SARS-CoV-2). While children appear to experience less severe disease than adults, those with underlying conditions such as kidney disease may be more susceptible to infection. Limited data are present for children with kidney disease, and there are limited prior reports of pediatric hemodialysis patients with COVID-19. This report describes the mild clinical disease course of COVID-19 in two pediatric patients with chronic kidney disease, one on hemodialysis and both on chronic immunosuppression. We review treatment in these patients, as well as our measures to reduce transmission among our hemodialysis patients and staff.


Subject(s)
COVID-19/therapy , Immunosuppression Therapy , Renal Dialysis , Renal Insufficiency, Chronic/complications , SARS-CoV-2 , Adolescent , COVID-19/prevention & control , Child , Humans , Male , Renal Insufficiency, Chronic/therapy
2.
J Pediatr Pharmacol Ther ; 19(3): 202-5, 2014 Jul.
Article in English | MEDLINE | ID: mdl-25309151

ABSTRACT

A 2-year-old male with chronic kidney disease with secondary hyperparathyroidism developed hypercalcemia while receiving calcitriol, without achieving a serum parathyroid hormone concentration within the goal range. Cinacalcet 15 mg (1.2 mg/kg), crushed and administered via gastrostomy tube, was added to the patient's therapy. This therapy was effective in achieving targeted laboratory parameters in our patient despite instructions in the prescribing information that cinacalcet should always be taken whole.

SELECTION OF CITATIONS
SEARCH DETAIL
...